2018

2nd semester

1
● Territorial Configuration
● Market Drivers / Coverage Profile
● Sales Performance
* Sales & Collection vs Target
* Sales & Collection (2018 vs 2017) / G
* MST & Trade (2018 vs 2017) / G
● SWOT Analysis
● ODA
● Highlights of the Month
● MST
* Per Product / Per SKU

2
 THERAPEUTIC
PSR DISTRICT TENURE
CLASS

WINSTON JAY LADERA CENTRAL VISAYAS OB/AI 7 YEARS &

8MONTHS

3
 MD 95
Prescribers 32
Dispensing 63
Total 95
Hospital 10
Government 4
Private 6
Total 10
MDC 16
Chain 3
Drugstores 8
Total 27
4
 No. of Frequency Class
TC % Shr
MD 4X 3X 2X A D M
Cardio
OB 25 21 4 5 15 5 26%
PEDIA 5 5 3 2 5%
SURGEON
FAMILY MED.
GENERAL PRACTITIONER
INTERNAL MED. 2 2
EENT
MIDWIVES/NURSES
DISPENSING with Regular
63 6 57 9 54 66%
Account
DISPENSING with Contract
DISPENSING (no Account)
Total 5
6
 MDC Trade Actual Target % PERF

103.4%
68,886 745,082 813,968 786,712.00
900,000.00
800,000.00
700,000.00
600,000.00
500,000.00
400,000.00
300,000.00
200,000.00
100,000.00
-
2018
ACTUAL 813,968.00
QUOTA 786,712.00
PERCENT 103.46%

8
8,000,000.00
7,000,000.00
6,000,000.00
5,000,000.00
4,000,000.00
3,000,000.00
2,000,000.00
1,000,000.00
-
AUGU
Dec Jan Feb March April May June July YTD
ST
2018 140,3 1,092 792,9 717,9 756,7 729,3 726,6 726,5 813,9 6,497
Target 786,7 786,7 786,7 786,7 786,7 786,7 786,7 786,7 786,7 7,080
Percentage 17.84% 138.92 100.79 91.26% 96.20% 93% 92% 92.35% 103.46 91.77%

9
8,000,000.00
7,000,000.00
6,000,000.00
5,000,000.00
4,000,000.00
3,000,000.00
2,000,000.00
1,000,000.00
-
IST QTR 2ND QTR 3RD QTR 4TH QTR TOTAL
ACTUAL 2,026,113.16 2,204,108.04 2,266,175.00 6,496,396.20
QUOTA 2,360,136.00 2,360,136.00 2,360,136.00 7,080,408.00
PERCENT 85.85% 93.39% 96.02% 91.75%

10
900,000.00
800,000.00
700,000.00
600,000.00
500,000.00
400,000.00
300,000.00
200,000.00
100,000.00
-
2018
ACTUAL 806,511.47
QUOTA 786,712.00
PERCENT 102.52%

11
MDC Trade Actual Target % PERF

68,886 737,625.47 806,511.47 786,712 102.52%

8,000,000.00
7,000,000.00
6,000,000.00
5,000,000.00
4,000,000.00
3,000,000.00
2,000,000.00
1,000,000.00
-
Dec Jan Feb March April May June July August YTD
2017 350,00 808,29 801,57 1,022, 673,86 733,23 708,23 729,96 806,51 6,634,
Target 786,71 786,71 786,71 786,71 786,71 786,71 786,71 786,71 786,71 7,080,
Percentage 44.49% 102.74% 101.89% 129.97% 85.66% 93% 90% 92.79% 102.52% 93.70%

13
6,000,000.00

5,000,000.00

4,000,000.00

3,000,000.00

2,000,000.00

1,000,000.00

(1,000,000.00)
Dec Jan Feb March April May June July August YTD
2018 140,331 1,092,8 792,917 717,956 756,779 729,374 726,665 726,524 806,511 5,683,4
2017 108,994 805,073 936,254 549,479 716,230 655,821 772,012 894,585 534,647 5,438,4
14
Growth 28.75% 35.75% -15.31% 31% 6% 11% -6% -19% 51% 5%
80,000.00
70,000.00
60,000.00
50,000.00
40,000.00
30,000.00
20,000.00
10,000.00
-
MDC
2018 68,886.00
2017 55,668.00
G 23.74%
800,000.00

700,000.00

600,000.00

500,000.00

400,000.00

300,000.00

200,000.00

100,000.00

(100,000.00)
Dec Jan Feb March April May June July July YTD
2018 36,293. 119,000 116,909 117,670 53,999 99,886 99,886 77,439 68,886 721,082
2017 47,000. 63,642. 88,954. 52,174. 82,415. 49,364. 104,760 94,234. 55,668. 582,544
16
Growth -22.78% 86.98% 31.43% 126% -34% 102% -5% -18% 24% 24%
4,500,000.00
4,000,000.00
3,500,000.00
3,000,000.00
2,500,000.00
2,000,000.00
1,500,000.00
1,000,000.00
500,000.00
-
MDC
2,018.00 3,932,674.75
2017 3,642,973.75
G 7.95%
 MDC
8%

TRADE
92%
 %
TC TRADE MDC 2018 TOTAL QUOTA

126,072 89,420 215,492 259,000 83%

OB

500,707.50 10,465.50 511,173 388,500 131.57%

AI

20
21
 CARDIOMET Price Actual Target Amount
APROVAZ150mg/12
600.00
.5mg Tablet
LACIBLOC 6mg
468.00
Tablet
ROSUVAZ 10mg FC
546.00
Tablet
ROSUVAZ 20mg FC
832.50
Tablet
TEROZIN 2mg
1,110.00
Tablet
TEROZIN 5mg
1,416.00
Tablet
CARDIOCARE
CATAMED 75mcg
2,200.00
Tablet
K-CHLOR 750mg SR
1,237.50
Tablet
KLOPIDE 75mg
855.00
Tablet
TRIVAN80mg
810.00
Tablet
TRIVAN PLUS
892.50
5mg/80mg Tablet
VASTAZID 35mg
420.00
Tablet
Total
100.00%
22
 OB Price Actual Target percentage
Ariane 2mg
320.00
/ 35mcg Tablet 205 133 154%
VITAGEL Softgel Capsule 1,475.00 5
30 16.6%
DUVAPRINE 10mg Tablet 450.00 35
34 102%
EVEROSE 1000mg softgel
720.00 50
Capsule 36 139%
Total

ERGOJEN 125mcg Tablet 1,950.00

12 3 400%
Folijen 5mg Capsule 650.00
10 11 91%
MARTHAM Capsule 750.00
1 17 5.8%
NAKARON Capsule 486.85
8 47 17%
DOPARINE 250mg Tablet 1,300.00
26 8 325%
DOXYLIN 100mg Capsule 4,975.00
4 7 57%
ROVIX 500mg Tablet 2,600.00
10 11 91%
ROVIX 750mg PFI
315.00
(I.M./I.V.) 50 12 416%
Total

23
 Price Actual Target Percentage

PEDIA PRODUCTS
CLOVIMAX
200mg/28.5mg 207.00
suspension
CLOVIMAX
400mg/57mg 420.00
Suspension 82 69 119%
SIGLATON 300 Plus
153.00
Syrup 36 127 28%
Trifix 10 mg./ml
196.50
Drops 10ML 43 49 88%
Trifix 10 mg./ml
575.00
Drops 30ML 21 25 84%
Total

24
 AI CORE Price Actual Target Percentage
LEVFLOX 500mg Tablet 1,800.00 8 8 100%
LEVFLOX 750mg Tablet 2,655.00
8 5 160%
PRADOL 325mg/37.50mg
2,520.00
FC Tablet 6 7 85%
SEDAZINE 10 mg FC
1,250.00
Tablet 6 7 85%
VINEURON PLUS
1,650.00
Capsule 20 8 250%
VINEURON Capsule
1,000.00 6 24 25%
ROVIX 125mg
275.00
Suspension 2 28 7%
ROVIX 250mg
395.00
Suspension 23 61 38%
CLOVIMAX
125mg/31.25mg 189.00
Suspension 78 25 312%
CLOVIMAX
250mg/62.50mg 342.25
Suspension 210 56 375%

CLOVIMAX
2,445.00
500mg/125mg Tablet
27 11 245%
SIGLATON Capsule 771.00 5 15 33%
Total

25
Comple Price Actual Target Percentage

VAMGESIC
50mg 74.00
Suspension 30 111 27%
VAMGESIC
735.00
500mg Capsule 3 19 16%
ELEOBRON GPC
69.00
60mL Syrup 72 42 171%%
ELEOBRON GPC
99.00
120mL Syrup 46 68 67.6%
ELEOMOX
68.00
100mg Drops 7
ELEOMOX
125mg 78.00
Suspension 6
ELEOMOX
250mg 124.00
Suspension 15
ELEOMOX
1,470.00
500mg Capsule 11
HALCEPIN
104.00
100mg Drops 9
HALCEPIN
125mg 132.00
Suspension 7

26
Products Price Actual Target Percentage
HALCEPIN 250mg Suspension 178.00 16

HALCEPIN 500mg Capsule 2,520.00 3

HALLEX x 120ml 111.00 13

HALLEX x 60ml 78.00 6

MICRANEX 500mg 1,680.00 3

SALVEX 2mg Syrup 63.00 324 23 1,408%

SALVEX XP 50mg/1mg Syrup 93.00 216 20 1,080%

SALVEX XP 100mg/2mg Tablet 788.00 378 4 9,450%

VALEMINE 4mg Tablet 116.00 4

VALEMINE 2mg Syrup 44.00 22

VAMCETIN 125mg 96.00 20

VEFAROL 125mg 252.00 3

VEFAROL 250mg 391.00 864 24 3,600%

VEXAMET 500mcg 152.00 10 6 166%

ZAMBOPRIM 200/40mg 93.00 15

Total
27
28
AFFORDABLE PRICE
NEW ADDITIONAL PRODUCTS
MORE MARKETING BUDGET
SMOOTH DELIVERIES

29
H Polymedic delayed payment

30
SPECIAL DEALS
SALES CONTRACT

31
 32

FOR 7 YEARS IVE BEEN WORKING IN

THIS COMPANY I OVERCOME ALL
THOSE THREATS ALREADY.BUT IF I
HAVE 1 THREAT MAYBE IF WE
CANNOT GIVE WHAT THE DOCTOR
REQUESTED.
33
 Duration Amount
Not Due 637,648.80

1-30 D 644,269.50

31-60 D 499,429.10

61-90 D 156,881 (8.24%)

above 90 D 16,054.38 (.84%)

Total Accnt. Receivables 1,904,978.16

Total ODA 172,935.38

% ODA 9%

34
35
 TOTAL CONTRACT ( AMOUNT ) =2,228,570.14
 TOTAL CONTRACT ( NUMBER) =3
 TOTAL MDs with CONTRACT =3

 TOTAL LAPSED CONTRACT ( AMOUNT) =9,000

 TOTAL LAPSED CONTRACT ( NUMBER) =1
 TOTAL MDs with Lapsed Contract =1

36
 TOTAL AMOUNT
NAME DURATION BALANCE REMARKS
CONTRACT

10MONTHS
1 DR. ROCHELLE PUDPUD 12MONTHS 685,000 570,833
REMAINING
1 MONTH
2 DR. AILEEN ALINSUB 12MONTHS 142,857.14 11,904.76
REMAINING
10MONTHS
3 DR. RONALD FLORES 12MONTHS 1,428,571.43 1,188,571.43
REMAINING
4 DR. EFREN CANILLAS LAPSE 9,000 BALANCE
5

7
8
9
10
11
 MD NAME PRODUCT DEAL AMOUNT

DR. MOISES OLAYVAR PRADOL & VAMGESIC 1+1 12,000

38
GENERIC - BRAND COMPETITOR

SULTAMICILLIN TOSYLATE- ZUNAMYN & UNASYN

39
40